metabolic explorer (metex.pa), a biological chemistry firm listed on france's cac 40 index, experienced an unexpected 34.45% share price drop over 21 sessions from eur1.19 to eur0.78, experiencing five straight loss sessions en route. despite an overall cac 40 index increase to eur7,240.88 this happened despite this dip.
stock performance overview
metabolic explorer's precipitous price decline puts it significantly below its 52-week peak of eur2.78. metabolic explorer closed last session trading at eur0.76, representing an incredible 72.64% drop from its 52-week high of eur2.78.
about metabolic explorer
metabolic explorer specializes in industrial fermentation processes as a greener alternative to petrochemical processes, offering its products globally from propanediol and butyric acid, glycolic acid, l-valine and more - used in products as diverse as cosmetics, textiles, polymers and animal nutrition as well as serving as foundation materials for biomaterial synthesis. established in 1999 and headquartered in saint-beauzire france since then; however, profitability issues persist at this company that was founded 17 years ago.
financial performance
metabolic explorer's earnings per share for the trailing twelve months was an alarming eur-1.13; furthermore, its return on equity--an indicator of how well a company generates profits using shareholders' equity--was at an alarming negative -39.56%, reflecting an alarming downward trend. these numbers demonstrate its financial hardships while seemingly reflecting in its stock prices as they drop further and further away.
more news about metabolic explorer (metex.pa).